Liver Stiffness predicts Early Virological Response (EVR) in HIV/HCV co-infected patients treated with Pegylated interferon alpha2a (PegIFN alpha 2a) plus Ribavirin (RBV)

被引：0
|
作者：
Nasta, P. [1 ]
Gatti, F. [1 ]
Borghi, F. [1 ]
Bianchi, E. [1 ]
Mendeni, M. [1 ]
Prestini, K. [1 ]
Carosi, G. [1 ]
机构：
[1] Univ Brescia, Ist Malattie Infett & Tropicali, I-25121 Brescia, Italy
来源：
INFECTION | 2010年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [21] EARLY VIROLOGICAL RESPONSE IS THE MAIN PREDICTORS OF VIRAL ERADICATION IN HCV HAEMODIALYSIS PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN
    Tucci, A.
    Rendina, M.
    Castellaneta, A.
    Castellaneta, N. M.
    Zappimbulso, M.
    Leandro, G.
    Chiala', C.
    Gesualdo, L.
    Di Leo, A.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E13 - E13
  • [22] EARLY VIROLOGICAL RESPONSE IS THE MAIN PREDICTOR OF VIRAL ERADICATION IN HCV HAEMODIALYSIS PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN
    Rendina, M.
    Tucci, A.
    Castellaneta, A.
    Castellaneta, N. M.
    Chiala', C.
    Leandro, G.
    Gesualdo, L.
    Di Leo, A.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S12 - S13
  • [23] EARLY VIROLOGICAL RESPONSE IS THE MAIN PREDICTOR OF VIRAL ERADICATION IN HCV HAEMODIALYSIS PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN
    Rendina, M.
    Tucci, A.
    Castellaneta, A.
    Castellaneta, N. M.
    Zappimbulso, M.
    Chiala, C.
    Leandro, G.
    di Leo, A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S333 - S333
  • [24] Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients
    Mira, Jose A.
    Valera-Bestard, Barbara
    Arizcorreta-Yarza, Ana
    Gonzalez-Serrano, Mercedes
    Torre-Cisneros, Julian
    Santos, Ignacio
    Vergara, Salvador
    Gutierrez-Valencia, Alicia
    Giron-Gonzalez, Jose A.
    Macias, Juan
    Lopez-Cortes, Luis F.
    Pineda, Juan A.
    ANTIVIRAL THERAPY, 2007, 12 (04) : 523 - 529
  • [25] The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon
    Marucco, D. Aguilar
    de Requena, D. Gonzalez
    Bonora, S.
    Tettoni, C.
    Bonasso, M.
    De Blasi, T.
    D'Avolio, A.
    Sciandra, M.
    Siccardi, M.
    Baietto, L.
    Trentini, L.
    Sinicco, A.
    Cariti, G.
    Di Perri, G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (04) : 919 - 924
  • [26] Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Berenguer, J.
    Gonzalez-Garcia, J.
    Lopez-Aldeguer, J.
    Von-Wichmann, M. A.
    Quereda, C.
    Hernando, A.
    Sanz, J.
    Tural, C.
    Ortega, E.
    Mallolas, J.
    Santos, I.
    Miralles, P.
    Montes, M. L.
    Bellon, J. M.
    Esteban, H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1256 - 1263
  • [27] Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin
    Nunez, M.
    Ocampo, A.
    Aguirrebengoa, K.
    Cervantes, M.
    Pascual, A.
    Echeverria, S.
    Asensi, V.
    Barreiro, P.
    Garcia-Samaniego, J.
    Soriano, V.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (05) : 363 - 369
  • [28] Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus
    Berenguer, Juan
    von Wichmann, Miguel A.
    Quereda, Carmen
    Miralles, Pilar
    Mallolas, Josep
    Lopez-Aldeguer, Jose
    Alvarez-Pellicer, Julio
    De Miguel, Julio
    Crespo, Manel
    Guardiola, Josep M.
    Tellez, Maria J.
    Galindo, Maria J.
    Arponen, Sari
    Barquilla, Elena
    Bellon, Jose M.
    Gonzalez-Garcia, Juan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (12) : 2843 - 2849
  • [29] Effect of Aging, Glucose Level, and HIV Viral Load on Response to Treatment with Pegylated Interferon Plus Ribavirin in HIV/HCV Co-Infected Women
    Nasta, Paola
    Maida, Ivana
    Cattelan, Anna Maria
    Pontali, Emanuele
    Angeli, Elena
    Giralda, Mariarosaria
    Verucchi, Gabriella
    Caputo, Antonietta
    Iannacone, Claudio
    Puoti, Massimo
    Carosi, Giampiero
    JOURNAL OF WOMENS HEALTH, 2015, 24 (02) : 159 - 164
  • [30] Therapeutical aspects and predictors of outcome for HIV/HCV co-infected patients treated with pegylated interferon plus ribavirin. Survey in an Italian university hospital
    Righi, E.
    Bassetti, M.
    Di Biagio, A.
    Dentone, C.
    Rosso, R.
    Beltrame, A.
    Mazzarello, G.
    Ratto, S.
    Viscoli, C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S543 - S543
12345